Mexico is implementing biometric technology to address the shortage of medications. According to Ulloa, this will allow the state to shift from a reactive to a preventive approach, optimizing budgets and ensuring access to treatment. In Mexico, access to prescribed medications is limited, resulting in millions of incomplete treatment cases. The contactless biometric technology from Identy.io ensures traceability in the supply chain, from specialized transport to final delivery to the patient. The solution allows logistics workers to use their mobile phones to control access to drug batches. When dispatching to the user, the technology validates identity through fingerprint scanning with a liveness check, ensuring the medication reaches the prescription holder and not third parties seeking to sell them illegally. The company's CEO stated that biometric technology should be a bridge to equity, not a barrier. After seven years of drug shortages, Mexico faces the challenge of transforming its healthcare management model. Experts point out that the use of Artificial Intelligence (AI) and advanced analytics could be an alternative to late reactions. Information on the experience in Germany and Denmark shows that analytical tools can predict vaccine needs, reducing shortages by 27% and replenishment times by 35%. Applying AI to logistics enables designing more efficient distribution routes, reducing waste due to expiration, and monitoring the cold chain in real-time via IoT sensors. The proposed "Smart Supply" model links each prescription to available inventory and the necessary logistics routes to fulfill it, closing the cycle until effective delivery to the patient and reducing emergency overpriced purchases.
